Concerns are growing over the non-medical use of prescription Attention-Deficit/Hyperactivity Disorder (ADHD) medication as a way to enhance academic performance. Often called “study drugs,” these medications are shared and discussed among students, prompting concerns about health risks, fairness, and proper medication use.

ADHD medications, often methylphenidate-based stimulants, are prescribed to help individuals manage attention and impulse control. When used without medical supervision, however, they can temporarily increase alertness and concentration, leading some students without a diagnosis to misuse them. In some cases, medication is obtained through peers or other unauthorized channels.

Experts suggest that intense academic pressure plays a significant role. Heavy workloads, high-stakes exams, and expectations for sustained focus may push students to seek pharmacological shortcuts to maintain productivity. The pressure to perform consistently at a high level can make short-term academic gains seem more urgent than long-term health considerations.

Medical professionals warn that misuse carries potential risks such as insomnia, anxiety, increased heart rate, and dependence. Most medical guidelines classify ADHD medications as prescription-only drugs and advise against non-medical use. Psychiatrists emphasize that appropriate treatment requires accurate diagnosis, individualized care, and regular monitoring.

As awareness of student mental health grows, experts stress the importance of accurate information and responsible attitudes toward medication. The issue highlights a broader challenge for education systems: supporting academic success while protecting student health and medical ethics.

박채은 강남포스트 학생기자  webmaster@ignnews.kr

<저작권자 © 강남포스트, 무단 전재 및 재배포 금지>